Key result
A review of the English literature confirms that neuroleptic malignant syndrome occurs with atypical antipsychotics, prompting evaluation of case reports for clinical characteristics.
Why the study?
What are the clinical characteristics of neuroleptic malignant syndrome induced by atypical antipsychotics compared to traditional antipsychotics?
What are the clinical characteristics of neuroleptic malignant syndrome induced by atypical antipsychotics compared to traditional antipsychotics?
Atypical antipsychotics can induce neuroleptic malignant syndrome, and reviewing case reports provides valuable information on its clinical course and risk factors.
No takes yet. Share an insight, caveat, or question.
Supports vigilance for NMS with atypical antipsychotics; leaves open whether features differ from conventional agents.
Debra Farver (2003) conducted a review in Neuroleptic malignant syndrome. Atypical antipsychotics (clozapine, risperidone, olanzapine, quetiapine) vs. Traditional antipsychotics was evaluated on Similarities or differences in NMS characteristics (diagnosis, age/sex, risk factors, doses, duration, symptoms, clinical course) compared to traditional antipsychotics. A review of the English literature confirms that neuroleptic malignant syndrome occurs with atypical antipsychotics, prompting evaluation of case reports for clinical characteristics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: